-
Consortium established to support ICH M7 compliance
europeanpharmaceuticalreview
August 01, 2017
An industry work-group comprising of toxicologists, pharmaceutical companies and data experts plans to unveil the early results of a data sharing project…
-
Canopy Biosciences announces agreement with Cosmo Bio
pharmaasia
July 25, 2017
Canopy Biosciences signs distribution agreement with Cosmo Bio to sell gene engineering products in Japan.
-
Future has “never been brighter” for US biopharmaceuticals
europeanpharmaceuticalreview
July 25, 2017
PhRMA report highlights the healthy nature of the US biopharmaceuticals industry
-
Deals this week: AMAG Pharmaceuticals, Noxxon Pharma, Teewinot Life Sciences
pharmaceutical-technology
May 08, 2017
US-based biopharmaceutical company AMAG Pharmaceuticals intends to raise $250m in gross proceeds through an underwritten public offering of convertible senior notes.
-
Deals this week: ContraVir Pharmaceuticals, UroGen Pharmaceuticals, Fresenius
pharmaceutical-technology
April 28, 2017
US-based ContraVir Pharmaceuticals will issue shares of its common stock and warrants to purchase shares in order to...
-
Sanofi and Regeneron’s Kevzara receives CHMP opinion to treat Rheumatoid Arthritis
pharmaceutical-technology.
April 26, 2017
Regeneron Pharmaceuticals and Sanofi’s Kevzara (sarilumab) has received a positive opinion from the European ...
-
Paratek and Zai Lab sign deal to commercialise omadacycline in China
pharmaceutical-technology
April 26, 2017
Paratek Pharmaceuticals has entered a collaboration with Chinese biopharmaceutical company Zai Lab (Shanghai) to support the development and commercialisation of omadacycline in China.
-
Valeant Pharmaceuticals lists price of plaque psoriasis drug at $3,500 per month
pharmaceutical-technology
April 25, 2017
Valeant Pharmaceuticals International has decided to set the price of its biologic psoriasis treatment, known as...
-
MPP signs licence and technology transfer agreement with Pharco Pharmaceuticals for RAV
pharmaceutical-technology
April 25, 2017
Public health organisation Medicines Patent Pool (MPP) has entered a new licence and technology transfer agreement...
-
PLx Pharma merges with Dipexium Pharmaceuticals
pharmaceutical-technology
April 21, 2017
Late-stage specialty pharmaceutical company PLx Pharma has completed its previously announced merger with Dipexium Pharmaceuticals.